A new coverage determination will prevent Medicare patients with certain cancers from accessing genetic testing, a move that advocates and testing companies say will severely limit early interventions ...
Medicare beneficiaries can receive Paxlovid at no cost through February 28, 2025. Paxlovid has become a pivotal treatment for COVID-19, particularly for individuals at high risk of severe illness.
Richard Timmins went to a free informational seminar to learn more about Medicare coverage. “I listened to the insurance agent and, basically, he really promoted Medicare Advantage,” Timmins said. The ...